Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Says Molecular Probes Acquisition to Close This Week

NEW YORK, Aug. 19 (GenomeWeb News) -Invitrogen said today it has received regulatory approval for its $325 million cash acquisition of Molecular Probes, and expects the acquisition to close this week.

 

The Carlsbad, Calif.-based company also said that it expects the acquisition to add to its earnings for 2003.

 

Invitrogen first announced the pending acquisition of privately-held Molecular Probes on July 2  The acquisition brings together Invitrogen, a genomic research reagents, software and service provider with the 28-year-old Eugene, Ore., provider of fluorescence-based technologies.

The Scan

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.